417 related articles for article (PubMed ID: 17915463)
21. [New technologies in the prevention, detection, diagnosis and treatment of tuberculosis in children].
Mitinskaia LA
Probl Tuberk; 2003; (1):19-24; discussion 24-5. PubMed ID: 12652978
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
[TBL] [Abstract][Full Text] [Related]
24. Current concept in the diagnosis and treatment of childhood pulmonary tuberculosis.
Singh UK; Suman S
J Indian Med Assoc; 1996 Oct; 94(10):381-4. PubMed ID: 9141878
[TBL] [Abstract][Full Text] [Related]
25. [Antituberculous measures according to the results of Mantoux test].
Guseĭnov GK; Mamaev IA; Abdulaeva ZK
Probl Tuberk; 2003; (1):14-7. PubMed ID: 12652976
[TBL] [Abstract][Full Text] [Related]
26. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
Pandey R; Sharma S; Khuller GK
Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
[TBL] [Abstract][Full Text] [Related]
27. Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.
Bartacek A; Schütt D; Panosch B; Borek M;
Int J Tuberc Lung Dis; 2009 Jun; 13(6):760-6. PubMed ID: 19460254
[TBL] [Abstract][Full Text] [Related]
28. Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?
Tortajada C; Martínez-Lacasa J; Sánchez F; Jiménez-Fuentes A; De Souza ML; García JF; Martínez JA; Caylà JA;
Int J Tuberc Lung Dis; 2005 Mar; 9(3):276-81. PubMed ID: 15786890
[TBL] [Abstract][Full Text] [Related]
29. Chemoprophylaxis with isoniazid in liver transplant recipients.
Fábrega E; Sampedro B; Cabezas J; Casafont F; Mieses MÁ; Moraleja I; Crespo J; Pons-Romero F
Liver Transpl; 2012 Sep; 18(9):1110-7. PubMed ID: 22645064
[TBL] [Abstract][Full Text] [Related]
30. [Ex juvantibus diagnosis in suspected skin tuberculosis].
Chuzhov AL; Ariél' BM; Bellendir EN; Belkova OV
Probl Tuberk Bolezn Legk; 2008; (12):15-8. PubMed ID: 19227320
[TBL] [Abstract][Full Text] [Related]
31. [Controlled clinical study on efficacy of fixed-dose compounds rifater/rifinah in antituberculous chemotherapy].
Zhu L; Yan B; Ma W
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):645-7. PubMed ID: 11477887
[TBL] [Abstract][Full Text] [Related]
32. [Differentiated approach to preventive treatment of new cases of tuberculosis in children].
Mordovskaia LI; Aksenova VA; Gavril'ev SS; Ivanova AP
Probl Tuberk; 2001; (2):14-7. PubMed ID: 11490456
[TBL] [Abstract][Full Text] [Related]
33. Isoniazid induced gynaecomastia: a case report.
Garg R; Vaibhav ; Mehra S; Prasad R
Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273
[TBL] [Abstract][Full Text] [Related]
34. [The evaluation of close contact case of pulmonary tuberculosis patients enrolled to Eskisehir Deliklitas Tuberculosis Control Dispensary].
Kolsuz M; Ersoy M; Küçükkebapçi C; Metintaş M; Uçgun I; Erginel S
Tuberk Toraks; 2003; 51(3):282-8. PubMed ID: 15143407
[TBL] [Abstract][Full Text] [Related]
35. How soon does cutaneous tuberculosis respond to treatment? Implications for a therapeutic test of diagnosis.
Ramam M; Mittal R; Ramesh V
Int J Dermatol; 2005 Feb; 44(2):121-4. PubMed ID: 15689209
[TBL] [Abstract][Full Text] [Related]
36. Latent tuberculosis infection in children: a call for revised treatment guidelines.
Finnell SM; Christenson JC; Downs SM
Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
[TBL] [Abstract][Full Text] [Related]
37. Adherence to isoniazid preventive therapy in children exposed to tuberculosis: a prospective study from Guinea-Bissau.
Gomes VF; Wejse C; Oliveira I; Andersen A; Vieira FJ; Carlos LJ; Vieira CS; Aaby P; Gustafson P
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1637-43. PubMed ID: 22118171
[TBL] [Abstract][Full Text] [Related]
38. [Preventive antituberculosis chemotherapy in 250 patients of the antituberculosis outpatient clinic in Lausanne].
Racine-Perreaud E; Zellweger JP
Schweiz Med Wochenschr; 1994 Apr; 124(17):705-11. PubMed ID: 8202667
[TBL] [Abstract][Full Text] [Related]
39. [Chemoprophylaxis of persons in dispensary registration group VII taking into account the risk factors of tuberculosis reactivation].
Kovaleva SI; Grebenkina AI; Gamperis IuL; Gavrilenko AF; Kuznetsova GG
Probl Tuberk; 1985; (10):8-11. PubMed ID: 4070209
[No Abstract] [Full Text] [Related]
40. [Short course chemotherapy for pulmonary tuberculosis. 3. Initial intensive regimens including pyrazinamide].
Suzuki T; Shimada M; Yamaguchi W; Kameda K; Okamura S; Aizawa H
Kekkaku; 1983 Sep; 58(9):459-64. PubMed ID: 6663962
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
